Abstract
Background
We present the case of a 55-year-old woman who underwent a Whipple procedure for pancreatic adenocarcinoma. The preoperative work-up showed no signs of liver metastasis and confirmed the patient’s operability, but at less than 40 days postoperatively there were diffuse liver metastasis present on CT. This rapid evolution raises the question whether current staging systems are adequate in determining a patient’s operability. It also suggests an interaction between the primary tumor and the host and the existence of disseminated tumor cells.
Discussion
In this article, we give an explanation for the clinical evolution presented in our case using the “integrated organ” and the “concomitant resistance” hypotheses. We believe that, if these theories continue to prove their viability, the search for disseminated tumor cells will be essential for good clinical practice in this type of pathology.
Similar content being viewed by others
References
Herrmann R, Jelic S. Pancreatic cancer: ESMO clinical recommendations for diagnosis, treatment and follow up. Ann Oncol. 2008;19(S2):ii25–6.
Robinson PJ. Imaging liver metastases: current limitations and future prospects. Br J Radiol. 2000;73:234–41.
Vogel I, Kalthoff H, Henne-Bruns D, Kremer B. Detection and prognostic impact of disseminated tumor cells in pancreatic carcinoma. Pancreatology. 2002;2:79–88.
Bernards R, Weinberg RA. A progression puzzle. Nature. 2002;418:823.
Pantel K, Brakenhoff RH. Dissecting the metastatic cascade. Nat Rev Cancer. 2004;4:448–56.
Hosch SB, Knoefel WT, Metz S, Stoeklein N, Niendorf A, Broelsch CE, et al. Early lymphatic tumor cell dissemination in pancreatic cancer: frequency and prognostic significance. Pancreas. 1997;15:154–9.
Fisher B. Laboratory and clinical research in breast cancer—a personal adventure: the David A. Karnofsky memorial lecture. Cancer Res. 1980;40:3863–74.
Wolfrum F, Vogel I, Fandrich F, Kalthoff. Detection and clinical implications of minimal residual disease in gastro-intestinal cancer. Langenbeck’s Arch Surg. 2005;390:430–41.
Su D, Yamaguchi K, Tanaka M. The characteristics of disseminated tumor cells in pancreatic cancer: a black box needs to be explored. Pancreatology. 2005;5:316–24.
Laird AK. Dynamics of tumor growth: comparison of growth rates and extrapolation of growth curve to one cell. Br J Cancer. 1965;29:278–91.
Miller BE, Miller FR, Wilburn DJ, Heppner GH. Analysis of tumor cell composition in tumours composed of paired mixtures of mammary tumor cell lines. Br J Cancer. 1988;56:561–6.
Miller RE, Miller FR, Wilburn D, Heppner GH. Dominance of a tumor subpopulation line in mixed heterogeneous mouse mammary tumors. Cancer Res. 1988;48:5747–53.
Korn JH, Downie E. Clonal interactions in fibroblast proliferation: recognition of self vs non self. J Cell Physiol. 1989;141:437–40.
Prehn RT. The inhibition of tumor growth by tumor mass. Cancer Res. 1991;51:2–4.
Prehn RT. Two competing influences that may explain concomitant tumor resistance. Cancer Res. 1993;53:3266–9.
Guba M, Cernaianu G, Koehl G, et al. A primary tumor promotes dormancy of solitary tumor cells before inhibiting angiogenesis. Cancer Res. 2001;61:5575–9.
Holmgren L, O’Reilly MS, Folkman J. Dormancy of micrometastases: balanced proliferation and apoptosis in the presence of angiogenesis suppression. Nat Med. 1995;1:149–53.
O’Reilly MS, Holmgren L, Chen C, Folkman J. Angiostatin induces and sustains dormancy of human primary tumors in mice. Nat Med. 1996;2:689–92.
Carmeliet P, Jain RK. Angiogenesis in cancer and other diseases. Nature (Lond). 2000;407:249–57.
Sckell A, Safabakhsh N, Dellian M, Jain RK. Primary tumor size-dependent inhibition of angiogenesis at a secondary site: an intravital microscopic study in mice. Cancer Res. 1998;58:5866–9.
Baum M, Demicheli R, Hrushesky W, Retsky M. Does surgery unfavourably perturb the “natural history” of early breast cancer by accelerating the appearance of distant metastasis? Eur J Cancer. 2005;41:508–15.
Braun S, Kentenich C, Janni W, Hepp F, de Waal J, Willgeroth F, et al. Lack of effect of adjuvant chemotherapy on the elimination of single dormant tumor cells in bone marrow of high-risk breast cancer patients. J Clin Oncol. 2000;18:80–6.
Muller V, Stahmann N, Riethdorf S, Rau T, Zabel T, Goetz A, et al. Circulating tumor cells in breast cancer: correlation to bone marrow micrometastases, heterogeneous response to systemic therapy and low proliferative activity. Clin Cancer Res. 2005;11:3678–85.
Demicheli R, Retsky MW, Hrushesky WJ, Baum M. Tumor dormancy and surgery-driven interuption of dormancy in breast cancer: learning from failures. Nat Clin Pract Oncol. 2007;4:699–710.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Deylgat, B., Van Rooy, F., Vansteenkiste, F. et al. Postsurgery Activation of Dormant Liver Micrometastasis: a Case Report and Review of Literature. J Gastrointest Canc 42, 1–4 (2011). https://doi.org/10.1007/s12029-010-9182-8
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12029-010-9182-8